VieCure, an AI-driven oncology platform, announced a $45 million funding round led by Northpond Ventures. The funds will be used to expand the company’s Halo Intelligence platform, which integrates clinical decision support with electronic medical records to personalize cancer treatment for community oncology care. The platform currently manages over 18,000 patients daily.
Richard Daly, a seasoned healthcare executive, joins as chairman of the board. Daly brings decades of experience in genomics and healthcare, aiming to accelerate VieCure’s platform expansion and improve patient outcomes across its national network of community cancer centers.
This AI-enabled solution addresses the growing complexity of precision oncology, providing oncologists with tools to manage personalized treatment plans, including multi-omic data integration. Daly expressed excitement for advancing VieCure’s impact on cancer care, highlighting the company's leadership in value-based healthcare solutions.
Click here to read the original news story.